Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
29.59
-0.69 (-2.28%)
Feb 2, 2026, 4:00 PM EST
SHA:603207 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 734.87 | 883.43 | 285.54 | 58.66 | 44.81 | 52.06 |
Short-Term Investments | - | - | - | 1.31 | 5.08 | - |
Trading Asset Securities | - | - | 2.97 | 108.96 | 158.11 | 60.63 |
Cash & Short-Term Investments | 734.87 | 883.43 | 288.52 | 168.93 | 208.01 | 112.69 |
Cash Growth | -13.75% | 206.20% | 70.79% | -18.79% | 84.58% | -3.42% |
Accounts Receivable | 115.03 | 90.29 | 85.39 | 81.88 | 55.82 | 70 |
Other Receivables | 0.41 | 2.21 | 2.06 | 0.82 | 0.72 | 3.73 |
Receivables | 115.44 | 92.5 | 87.46 | 82.69 | 56.55 | 73.74 |
Inventory | 52.65 | 45.21 | 49.9 | 57.2 | 53.37 | 40.22 |
Other Current Assets | 28.18 | 10.8 | 26.19 | 19.04 | 8.45 | 3.98 |
Total Current Assets | 931.14 | 1,032 | 452.06 | 327.87 | 326.37 | 230.63 |
Property, Plant & Equipment | 346.42 | 338.04 | 226.57 | 62.97 | 25.75 | 14.52 |
Long-Term Investments | - | - | - | - | 1.27 | 6.19 |
Other Intangible Assets | 23.34 | 24.53 | 26.12 | 27.7 | 29.23 | 30.81 |
Long-Term Deferred Tax Assets | 3.02 | 3.36 | 2.86 | 2.27 | 2 | 1.44 |
Long-Term Deferred Charges | 2.18 | 1.32 | 0.47 | 0.49 | 0.74 | 0.62 |
Other Long-Term Assets | 1.52 | 3.26 | 4.58 | 42 | 0.67 | 0.38 |
Total Assets | 1,308 | 1,402 | 712.65 | 463.3 | 386.02 | 284.58 |
Accounts Payable | 41.47 | 23.09 | 19.61 | 27.42 | 16.61 | 22.12 |
Accrued Expenses | 7.81 | 36.34 | 38.38 | 28.91 | 34.34 | 30.33 |
Short-Term Debt | 1.78 | 1.65 | - | - | - | - |
Current Portion of Leases | - | 0.67 | 0.42 | - | - | - |
Current Income Taxes Payable | 10.83 | 7.13 | 5.33 | 12.5 | 13.71 | 12.87 |
Current Unearned Revenue | 0.42 | 0.89 | 0.61 | 1.55 | 11.79 | 1.29 |
Other Current Liabilities | 191.18 | 98.38 | 67.82 | 19.58 | 79.09 | 2.26 |
Total Current Liabilities | 253.48 | 168.15 | 132.18 | 89.96 | 155.55 | 68.86 |
Long-Term Leases | - | - | 0.44 | 0.88 | 1.27 | - |
Long-Term Unearned Revenue | 0.06 | 0.07 | 0.08 | 0.09 | 0.1 | 0.12 |
Total Liabilities | 253.53 | 168.21 | 132.7 | 90.94 | 156.92 | 68.97 |
Common Stock | 160.56 | 160 | 120 | 120 | 120 | 32 |
Additional Paid-In Capital | 488.02 | 478.23 | 69.22 | 65.25 | 61.18 | 0.25 |
Retained Earnings | 412.67 | 596.01 | 390.73 | 187.11 | 47.93 | 183.36 |
Shareholders' Equity | 1,054 | 1,234 | 579.95 | 372.36 | 229.11 | 215.61 |
Total Liabilities & Equity | 1,308 | 1,402 | 712.65 | 463.3 | 386.02 | 284.58 |
Total Debt | 1.78 | 2.32 | 0.86 | 0.88 | 1.27 | - |
Net Cash (Debt) | 733.09 | 881.11 | 287.65 | 168.05 | 206.74 | 112.69 |
Net Cash Growth | -13.95% | 206.31% | 71.17% | -18.71% | 83.45% | -3.42% |
Net Cash Per Share | 4.56 | 6.57 | 2.40 | 1.40 | 1.72 | - |
Filing Date Shares Outstanding | 158.64 | 160.56 | 160 | 120 | 120 | - |
Total Common Shares Outstanding | 158.64 | 160 | 120 | 120 | 120 | - |
Working Capital | 677.66 | 863.79 | 319.89 | 237.9 | 170.83 | 161.77 |
Book Value Per Share | 6.64 | 7.71 | 4.83 | 3.10 | 1.91 | - |
Tangible Book Value | 1,031 | 1,210 | 553.84 | 344.66 | 199.88 | 184.8 |
Tangible Book Value Per Share | 6.50 | 7.56 | 4.62 | 2.87 | 1.67 | - |
Buildings | - | 26.35 | 26.35 | 26.35 | 25.62 | 25.9 |
Machinery | - | 36.94 | 35.52 | 35.19 | 32.62 | 31.75 |
Construction In Progress | - | 329.17 | 216.53 | 50.04 | 12.67 | 0.73 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.